China Healthcare Weekly (Dec.25)
This article analyzed healthcare industry viewpoints such as competitive landscape of PD-1/L1 in China, news of Alphamab, Hengrui, Innovent and...
477 Views
Biden COVID-19 Response Plan: Overview of Its Inherent Investment Themes
Biden's recently-announced COVID-19 response plan suggests a number of investment themes. This Insight overviews the more significant of those...
288 Views
Smartkarma Originals
Asian Healthcare - Coming of Age
This Smartkarma Originals Insight highlights 20 leading unlisted healthcare companies in Asia, mainly in digital healthcare and biopharma, that are...
1k Views
Insights on China Genetic Testing Industry
This article analyzed China genetic testing industry in the perspective of favorable policy, market potential, future trend, investment trend in...
520 Views
Biolidics, iX Biopharma & Hyphens Pharma Outpace Peers in 2020 YTD
Singapore’s most traded primary-listed stocks that represent medical equipment manufacturing, biotech and pharmaceuticals all generated gains...
168 Views